Drug Shortage Report for MYLAN-INDAPAMIDE

Last updated on 2022-03-10 History
Report ID 155442
Drug Identification Number 02153483
Brand name MYLAN-INDAPAMIDE
Common or Proper name INDAPAMIDE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) INDAPAMIDE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-15
Estimated end date 2022-03-08
Actual end date 2022-03-09
Shortage status Resolved
Updated date 2022-03-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-03-10 English Compare
v6 2022-03-09 French Compare
v5 2022-03-09 English Compare
v4 2022-03-02 French Compare
v3 2022-03-02 English Compare
v2 2022-02-23 French Compare
v1 2022-02-23 English Compare

Showing 1 to 7 of 7